Clinical Trial Update: A Study of Ixekizumab in Participants With Plaque Psoriasis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for ixekizumab in plaque psoriasis with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Ixekizumab (ixekizumab)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Psoriasis | Phase 1 | Status: COMPLETED | Results posted: 2019-03-12